Biogen: project for new plant for gene therapy
(CercleFinance.com) - Biogen announces its intention to build a new gene therapy manufacturing facility at Research Triangle Park (RTP) in North Carolina, to support its growing pipeline in several therapeutic areas.
Gene therapy is an emerging therapeutic modality that may be suitable for a growing list of genetically validated targets in neuroscience, it said.
The new facility, which will cover an area of over 16,000 m2, is expected to employ around 90 people and be operational by 2023. It will mean a total investment that is estimated at around 200 million dollars.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
Gene therapy is an emerging therapeutic modality that may be suitable for a growing list of genetically validated targets in neuroscience, it said.
The new facility, which will cover an area of over 16,000 m2, is expected to employ around 90 people and be operational by 2023. It will mean a total investment that is estimated at around 200 million dollars.
Copyright (c) 2021 CercleFinance.com. All rights reserved.